- Home
- QNRX vs SDSTW Comparison
QNRX vs SDSTW Comparison
Compare QNRX & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- SDSTW
- Stock Information
- Founded
- QNRX 2018
- SDSTW N/A
- Country
- QNRX United States
- SDSTW United States
- Employees
- QNRX N/A
- SDSTW 8
- Industry
- QNRX Medical/Dental Instruments
- SDSTW
- Sector
- QNRX Health Care
- SDSTW
- Exchange
- QNRX Nasdaq
- SDSTW Nasdaq
- Market Cap
- QNRX 4.3M
- SDSTW 3.7M
- IPO Year
- QNRX N/A
- SDSTW N/A
- Fundamental
- Price
- QNRX $7.20
- SDSTW $0.07
- Analyst Decision
- QNRX
- SDSTW
- Analyst Count
- QNRX 0
- SDSTW 0
- Target Price
- QNRX N/A
- SDSTW N/A
- AVG Volume (30 Days)
- QNRX 4.5K
- SDSTW 41.6K
- Earning Date
- QNRX 08-07-2025
- SDSTW 03-26-2025
- Dividend Yield
- QNRX N/A
- SDSTW N/A
- EPS Growth
- QNRX N/A
- SDSTW N/A
- EPS
- QNRX N/A
- SDSTW N/A
- Revenue
- QNRX N/A
- SDSTW N/A
- Revenue This Year
- QNRX N/A
- SDSTW N/A
- Revenue Next Year
- QNRX N/A
- SDSTW N/A
- P/E Ratio
- QNRX N/A
- SDSTW N/A
- Revenue Growth
- QNRX N/A
- SDSTW N/A
- 52 Week Low
- QNRX $5.01
- SDSTW $0.10
- 52 Week High
- QNRX $54.95
- SDSTW $0.12
- Technical
- Relative Strength Index (RSI)
- QNRX 43.44
- SDSTW N/A
- Support Level
- QNRX $7.05
- SDSTW N/A
- Resistance Level
- QNRX $7.30
- SDSTW N/A
- Average True Range (ATR)
- QNRX 0.33
- SDSTW 0.00
- MACD
- QNRX 0.05
- SDSTW 0.00
- Stochastic Oscillator
- QNRX 41.14
- SDSTW 0.00
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).